Center Laboratories, Inc. (4123.TWO)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Su-Chi Wang | CEO, Chief Investment Officer, COO & Chairman | 4.72M | -- | -- |
Ms. Min-Li Lien | Assistant Vice President of Legal Affairs Department | 2.3M | -- | -- |
Mr. Jui-Pao Hsu | General President of Pharmaceutical Business | 3.47M | -- | -- |
Ms. Ching-Yu Tang | Head of Corporate Governance | 1.87M | -- | -- |
Ms. Chiun-Yu Lin | Plant Director | 2.27M | -- | -- |
An-Ni Mao | Manager of Finance & Accounting Department | -- | -- | -- |
Ms. Hsiu Yueh Lin | Director of Administration Department | -- | -- | -- |
Center Laboratories, Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells. In addition, the company engages in drug development, cell therapy, biotechnology, biopharmaceutical, hydrogen energy, and dairy business. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
Corporate Governance
Upcoming Events
August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC
Center Laboratories, Inc. Earnings Date
Recent Events
August 2, 2024 at 12:00 AM UTC
Ex-Dividend Date